Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age.
Bijukchhe SM. et al, (2024), Vaccine, 42, 2018 - 2025
Molecular correlates of vaccine-induced protection against typhoid fever.
Zhu H. et al, (2023), J Clin Invest, 133
Distinct glycosylation and functional profile of typhoid vaccine-induced antibodies in a UK challenge study and Nepalese children.
HILL J. et al, (2022), Frontiers in Analytical Science
Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.
Barton A. et al, (2022), Infect Immun, 90
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.
Shakya M. et al, (2021), Lancet Glob Health, 9, e1561 - e1568
Persistence of Antibody After a Vi-Tetanus Toxoid Conjugate Vaccine and Effect of Boosting With a Plain Polysaccharide Vaccine on Vi Antibody and Antigen-Specific B Cells
Bentley T. et al, (2021), Frontiers in Tropical Diseases, 2
Association of Antibody-Dependent Neutrophil Phagocytosis With Distinct Antibody Glycosylation Profiles Following Typhoid Vaccination
Johnson M. et al, (2021), Frontiers in Tropical Diseases, 2
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Voysey M. et al, (2021), Lancet, 397, 881 - 891
Vi-specific serological correlates of protection for typhoid fever.
Jin C. et al, (2021), J Exp Med, 218
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
Voysey M. and Pollard AJ., (2020), Lancet, 396, 1486 - 1487
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
Gibani MM. et al, (2020), PLoS Negl Trop Dis, 14
Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.
Rigsby P. et al, (2020), Biologicals, 66, 21 - 29
Vi-Vaccinations Induce Heterogeneous Plasma Cell Responses That Associate With Protection From Typhoid Fever.
Cross DL. et al, (2020), Front Immunol, 11
Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model.
Gibani MM. et al, (2019), Nat Med, 25, 1082 - 1088
The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
Gibani MM. et al, (2019), Clin Infect Dis, 68, 1265 - 1273
IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model.
Dahora LC. et al, (2019), Front Immunol, 10
Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model.
Juel HB. et al, (2017), Front Immunol, 8